Ad sends us a message
Throughout his life, baby boomer Ad had always been healthy and strong, active and, as his wife Annie will tell you, a man of many trades. (If the job exists – whether here in the Netherlands or anywhere else – he’s probably done it!) In fact, it was during a pre-employment physical for a new job that Ad’s CNM diagnosis was made.
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases. The Dynacure team leverages its proven track record in rare disease drug development to build a pipeline of novel drugs. Dynacure is developing DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 for the treatment of Centronuclear Myopathies, with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders.